Does Urolithin A Work? What the Research and Users Say

"Does it work?" is the right question to ask of any supplement. For urolithin A, the honest answer is more interesting than a simple yes or no: there is real human trial data in specific areas, a larger body of early animal and cell research in others, and a clear pattern in who tends to see the most from it. Here is what the evidence actually supports.

First, what urolithin A is supposed to do

Urolithin A is a gut postbiotic. You do not absorb it directly from food; instead, your microbiome converts ellagitannins — compounds in pomegranates, walnuts, and berries — into urolithin A during digestion. The catch is that only some people carry the bacteria to produce meaningful amounts, which is why a standardized supplement dose exists at all. Its most-studied mechanism is support for mitophagy: the housekeeping process by which cells recycle worn-out mitochondria so the remaining pool works more efficiently. Because mitochondria are the cell's energy producers, the research interest centers on tissues with high energy demand — muscle in particular. If you want the underlying biology, see what is mitophagy and mitochondrial health.

The strongest evidence: human randomized trials

What separates urolithin A from many novelty ingredients is that it has been through placebo-controlled human trials. This is the tier of evidence that matters most, so it belongs first.

Muscle endurance and strength

In a randomized controlled trial by Liu and D'Amico published in JAMA Network Open in 2022 (5:e2144279), older adults took urolithin A for roughly four months, and the study reported effects on muscle endurance — measured as the number of muscle contractions performed before fatigue. Separately, the four-month trial by Singh and colleagues in Cell Reports Medicine in 2022 (PubMed 35584623) enrolled middle-aged adults across 500 mg and 1,000 mg arms and reported measures related to muscle strength and exercise performance. Two independent randomized trials pointing in the same direction on muscle-related outcomes is the most substantive part of the human case. For more on this, see urolithin A for muscle.

Mitochondrial and cellular signals

The first-in-human study — Andreux and colleagues in Nature Metabolism, 2019 — established that urolithin A was safe and well tolerated up to 1,000 mg per day and reported a mitochondrial gene-expression signature, providing a human fingerprint consistent with the proposed mechanism rather than only an animal one.

Immune-cell mitochondrial health

A more recent randomized controlled trial in Nature Aging (2025, PubMed 41174221) ran about 28 days and reported support for immune-cell mitochondrial health in midlife adults, examined in the context of age-related low-grade inflammation sometimes called inflammaging.

Exercise, endurance, and recovery in trained people

Beyond older and midlife populations, an eight-week randomized controlled trial in the Journal of the International Society of Sports Nutrition (2024, doi 10.1080/15502783.2024.2419388) studied resistance-trained men and looked at endurance and recovery markers, and a 2025 trial in distance runners (PMC12628386) extended the research into an endurance-athlete population. This body of work is why urolithin A is discussed for energy and physical performance, always within structure and function support rather than as a treatment.

The earlier tier: preclinical research

A lot of the excitement around urolithin A traces back to animal and cell studies. These are genuinely important for understanding mechanism, but they are not human proof, and it is worth labeling them plainly as preclinical.

The foundational work is Ryu and colleagues in Nature Medicine (2016), which showed that urolithin A induced mitophagy and was associated with extended lifespan in the worm C. elegans and improved muscle function in rodents. That animal signal is what motivated the human trials that followed. In the joint space, D'Amico and colleagues in Aging Cell (2022, PubMed 35778837) examined cartilage and joint-related mitochondrial health in osteoarthritis models — again, animal and cell work, not a human joint trial. Other areas people ask about — skin, gut, brain, and heart — remain at the stage where early, preclinical research is exploring possibilities, without the human randomized data that exists for muscle. Keeping this distinction clear is the difference between an evidence-first read and hype.

So, does it work? An honest verdict

The most balanced summary comes from the systematic review "Targeting aging with urolithin A in humans" (Ageing Research Reviews, 2024), which concludes that the human evidence is still emerging — promising in specific areas, but built on relatively short trials with modest sample sizes. Put simply: the human data is strongest and most consistent for muscle-related outcomes and for markers of mitochondrial and immune-cell health, and it is real. For skin, brain, heart, joints, and similar areas, the science is earlier and largely preclinical. Urolithin A is not a treatment for any condition and is not intended to diagnose, treat, cure, or prevent disease; it is not a substitute for medical care, so for any health concern, see your doctor.

Why dose and consistency decide your result

Whether urolithin A "works" for a given person depends heavily on how it is used. Three factors stand out.

Dose within the studied range

The trials that reported benefits used 500 to 1,000 mg per day. A product delivering far less than the studied amount is unlikely to reproduce trial conditions. Staying inside that window — with 1,000 mg at the top — is how you match the research. Our urolithin A dosage guide breaks this down.

Consistency over weeks and months

The successful trials ran from about four weeks to four months of daily use. Urolithin A is studied as a sustained daily input, not a same-day boost, so a few scattered doses will not mirror the studies. See how long urolithin A takes to work for realistic timelines.

Your starting point and your microbiome

Because natural urolithin A production varies so much between people, a standardized dose is what levels the field. It also means baseline matters: individual responses differ, and a supplement is one input among diet, training, and sleep. For product comparison, our roundup of the best urolithin A gummies and the broader urolithin A guide are good next reads.

What users tend to report

Anecdotal experience is not evidence in the way a randomized trial is, and it cannot establish that a product works. That said, the reason people stay consistent is usually that they are pursuing the outcomes the human trials examined — support for physical performance and everyday energy — over a period of weeks to months. The practical lesson from both the data and the anecdotes is the same: match the studied dose, take it daily, and give it a fair, sustained trial rather than judging it in a few days.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.